Literature DB >> 2283277

The biochemical diagnosis of lysosomal storage diseases--a review of five years experience.

I J Wallace1, C A McCusker, D McCormick.   

Abstract

The inherited lysosomal storage diseases are a distinct group of inborn errors of metabolism characterised by deficiencies in specific lysosomal enzymes. As many as 40 such disorders have now been described in man. We have measured the activities of up to 16 lysosomal acid hydrolases in plasma and/or extracts of leucocytes and cultured skin fibroblasts from 198 patients referred from throughout Ireland. These 16 assays allowed the biochemical diagnosis of 20 lysosomal storage diseases. Activities were compared with reference ranges to determine homozygotes and heterozygotes. Of the 44 patients with positive results, 15 were diagnosed as being homozygous for a specific lysosomal enzyme deficiency, 4 were identified as having multiple enzyme deficiencies (mucolipidosis Type II/I-cell disease) and 25 had heterozygote (carrier) enzyme levels. Of the latter, 24 were either parents (obligate heterozygotes) or siblings of homozygotes and one was a heterozygote for the X-linked recessively inherited Fabry's disease.

Entities:  

Mesh:

Year:  1990        PMID: 2283277     DOI: 10.1007/bf02937266

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  33 in total

1.  Rapid method for measuring arylsulfatase A and B in leucocytes as a diagnosis for sulfatidosis, mucosulfatidosis and mucopolysaccharidosis VI.

Authors:  R Humbel
Journal:  Clin Chim Acta       Date:  1976-05-03       Impact factor: 3.786

Review 2.  INBORN LYSOSOMAL DISEASES.

Authors:  H G HERS
Journal:  Gastroenterology       Date:  1965-05       Impact factor: 22.682

3.  Human leukocyte acid hydrolases: characterization of eleven lysosomal enzymes and study of reaction conditions for their automated analysis.

Authors:  E H Kolodny; R A Mumford
Journal:  Clin Chim Acta       Date:  1976-07-15       Impact factor: 3.786

Review 4.  Displacement bone marrow transplantation and immunoprophylaxis for genetic diseases.

Authors:  J R Hobbs
Journal:  Adv Intern Med       Date:  1988

5.  GM2-gangliosidosis variant with altered substrate specificity: evidence for alpha-locus genetic compound.

Authors:  G T Besley; D M Broadhead; J A Young
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

6.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Authors:  T R Chen
Journal:  Exp Cell Res       Date:  1977-02       Impact factor: 3.905

7.  Arylsulfatase B deficiency in Maroteaux-Lamy syndrome cultured fibroblasts.

Authors:  A L Fluharty; R L Stevens; D L Sanders; H Kihara
Journal:  Biochem Biophys Res Commun       Date:  1974-07-24       Impact factor: 3.575

8.  Studies on pyrophosphate diesterase activity in cultured human fibroblasts: a deficiency in Niemann-Pick disease.

Authors:  G T Besley; S E Moss
Journal:  Clin Chim Acta       Date:  1981-11-25       Impact factor: 3.786

9.  Specific inactivation of lysosomal glycosidases in living fibroblasts by the corresponding glycosylmethyl-p-nitrophenyltriazenes.

Authors:  O P Van Diggelen; H Galjaard; M L Sinnott; P J Smith
Journal:  Biochem J       Date:  1980-05-15       Impact factor: 3.857

10.  Tay-Sachs disease: prenatal diagnosis.

Authors:  J S O'Brien; S Okada; D L Fillerup; M L Veath; B Adornato; P H Brenner; J G Leroy
Journal:  Science       Date:  1971-04-02       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.